Wilson Sonsini Goodrich & Rosati and Osler, Hoskin & Harcourt advised Clio on the transaction. Clio announced the closing of its US$900-million Series F investment round,...
You must be a Standard 1 Year member to access this content.
BRANDL TALOS and Cooley advised Tipico on the deal. MGM Resorts International was advised by Wilson Sonsini Goodrich & Rosati. Tipico Group Ltd., one of the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on IP matters related to the transaction. Third Arc Bio Inc., a biotech company, announced a $165 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Digestiva in the transaction. Digestiva, a leading food biotech company, announced it closed its Series A equity financing round, raising...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cloverleaf on the transaction, and Kirkland & Ellis advised Sandbrook Capital. Cloverleaf Infrastructure (Cloverleaf) announced that it has secured capital...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Armada in the transaction. Armada announced its $40 million funding round led by M12 (Microsoft’s Venture Fund), raising its total...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Regard in the financing. Regard, an AI-powered clinical insights platform, announced the close of a $61 million Series B financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised LENZ Therapeutics on the transaction. LENZ Therapeutics (Nasdaq: LENZ), a late clinical-stage biopharmaceutical company, announced that it has entered into...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Valor Capital on the transaction. Partior, a fintech company, announced the close of a $60 million Series B round. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Adona Medical on the transaction. Adona Medical, Inc. is a Shifamed portfolio company that aims to deliver advanced solutions for...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Seismos on the transaction. Seismos, Inc., a leader in AI-powered Acoustic Sensing, and growth equity firm Edison Partners announced a...
You must be a Standard 1 Year member to access this content.
